Turning Science into Consumer Brands
HBI is committed to translating innovative science into meaningful consumer brands.
Healthcare Brands International (HBI) is a company, established in the UK in October 2006, and participating primarily in the growing market of OTC Medicines, medical devices and other healthcare products and services. We are committed to help innovators commercialise their technology to create sustainable businesses and brands.
Following the successful exit from Erazaban, Sambucol and most recently Antula Healthcare in Sweden, we have returned significant proceeds to our original investors.
We are interested to help commercialise interesting new technology, with meaningful , substantiated and protected differentiation, especially when addressing as yet unmet needs in the market.